Written question asked by Neale Hanvey (Alba Party) on Tuesday, 26 March 2024, in the House of Commons. It was due for an answer on Monday, 15 April 2024. It was answered by Maria Caulfield (Conservative) on Monday, 15 April 2024 on behalf of the Department of Health and Social Care.

Coronavirus: Vaccination

Question: To ask the Secretary of State for Health and Social Care, whether the Medicines and Healthcare products Regulatory Agency has (a) requested and (b) reviewed data from the expert review panel set up by the Norwegian government into the cause of death in relation to patients who have received a Covid 19 vaccine.

Answer: Following the initial roll out of the COVID-19 vaccination programme in December 2020, the Medicines and Healthcare products Regulatory Agency (MHRA) had a comprehensive surveillance strategy in place, enabling continual close monitoring of emerging safety evidence, including relevant safety information from international regulators. This included engagement with the European Medicines Agency to discuss data emerging from European Member States and countries in the European Economic Area, such as Norway. The MHRA communicates safety advice based upon consideration of the totality of evidence from all relevant information sources, rather than the strengths and limitations of individual data sources.

Secondary information

Type: Written question
Reference: 20789
Session: 2023-24
Subjects: Death Norway Research Vaccination Medicines and Healthcare products Regulatory Agency Coronavirus
Link: View this Written question on www.parliament.uk